company background image
600998 logo

Jointown Pharmaceutical Group SHSE:600998 Stock Report

Last Price

CN¥5.23

Market Cap

CN¥25.7b

7D

-3.0%

1Y

-10.2%

Updated

23 Nov, 2024

Data

Company Financials +

Jointown Pharmaceutical Group Co., Ltd

SHSE:600998 Stock Report

Market Cap: CN¥25.7b

Jointown Pharmaceutical Group Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jointown Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥5.23
52 Week HighCN¥6.94
52 Week LowCN¥4.35
Beta0.21
11 Month Change1.95%
3 Month Change12.96%
1 Year Change-10.16%
33 Year Change1.32%
5 Year Change4.17%
Change since IPO-25.85%

Recent News & Updates

We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Nov 17
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Recent updates

We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Nov 17
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Aug 29
Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

Aug 26
Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Aug 01
These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jun 07
Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

May 21
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Apr 05
Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Shareholder Returns

600998CN HealthcareCN Market
7D-3.0%-2.0%-2.1%
1Y-10.2%-17.0%2.8%

Return vs Industry: 600998 exceeded the CN Healthcare industry which returned -17% over the past year.

Return vs Market: 600998 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 600998's price volatile compared to industry and market?
600998 volatility
600998 Average Weekly Movement6.7%
Healthcare Industry Average Movement8.7%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600998 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600998's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199930,100Wei Hewww.jztey.com

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines.

Jointown Pharmaceutical Group Co., Ltd Fundamentals Summary

How do Jointown Pharmaceutical Group's earnings and revenue compare to its market cap?
600998 fundamental statistics
Market capCN¥25.69b
Earnings (TTM)CN¥2.05b
Revenue (TTM)CN¥149.20b

12.6x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600998 income statement (TTM)
RevenueCN¥149.20b
Cost of RevenueCN¥137.45b
Gross ProfitCN¥11.75b
Other ExpensesCN¥9.70b
EarningsCN¥2.05b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.42
Gross Margin7.88%
Net Profit Margin1.37%
Debt/Equity Ratio43.1%

How did 600998 perform over the long term?

See historical performance and comparison

Dividends

3.7%

Current Dividend Yield

48%

Payout Ratio